-
Bexson Biomedical Closes $4.8M Series A Financing To Develop Wearable Ketamine Technology
Tuesday, February 2, 2021 - 9:42am | 493Pharmaceutical startup Bexson Biomedical confirmed Monday the closing an oversubscribed Series A funding round. The $4.8 million raise was led by Greyhouse Partners' Noetic Psychedelic Fund. Noetic advisor Warren Wright also agreed to join Bexson’s board of directors, supporting...